Form 4: Astera Labs CEO Sells Over 52,000 Shares Under Pre-Arranged Trading Plan

Astera Labs, Inc. CEO Jitendra Mohan has sold 52,743 shares of common stock for approximately $5.32 million through a pre-scheduled Rule 10b5-1 trading plan.

Summary

• Jitendra Mohan, the Chief Executive Officer and a Director of Astera Labs, Inc. (ALAB), executed the sale of common stock.
• A total of 52,743 shares of Astera Labs common stock were sold on June 20, 2025.
• The sales were conducted at a weighted average price of $100.8573 per share, totaling approximately $5,319,900.
• The shares were sold in multiple transactions, with 27,056 shares sold between $100.0000 and $100.9900, and 25,687 shares sold between $100.9950 and $101.7300.
• The transactions were made automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Mohan on December 2, 2024.
• Following these transactions, Mr. Mohan directly holds 2,262,318 shares and indirectly holds 7,613,200 shares through various trusts (Living Trust, Trust, 2021 Trust 1, 2021 Trust 2, 2022 Trust 1, and 2022 Trust 2).

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the CEO's sale of a significant number of shares. While the Rule 10b5-1 plan mitigates the immediate negative signal by indicating a pre-scheduled transaction rather than a reactive one, insider selling by a top executive is generally not viewed favorably by the market.

Negatives

• The sale of a significant number of shares by the Chief Executive Officer, even under a pre-arranged plan, can be perceived by some investors as a negative signal regarding management's confidence in the company's near-term stock price potential.
• Insider selling, particularly by a top executive, may lead to increased selling pressure on the stock in the short term.

Risks

• Market perception risk: Despite being pre-planned, insider sales can sometimes be misinterpreted by the market, potentially leading to negative sentiment or a temporary dip in share price.
• Liquidity risk: While the sale provides liquidity to the insider, it adds shares to the market, which could impact supply-demand dynamics.

Future Outlook

This Form 4 filing pertains to an insider stock transaction and does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

This filing is specific to an insider transaction at Astera Labs and does not provide broader industry context or trends. It reflects an individual executive's pre-planned stock diversification or liquidity management.

Related Party Transactions

• The transactions involve the sale of shares by Jitendra Mohan, the CEO and a Director of Astera Labs, Inc., making him a related party.
• A significant portion of Mr. Mohan's remaining beneficial ownership is held indirectly through various estate planning trusts (Living Trust, Trust, 2021 Trust 1, 2021 Trust 2, 2022 Trust 1, 2022 Trust 2), for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: May interpret the CEO's share sale as a signal about the company's valuation or future prospects, potentially influencing their investment decisions.
• Employees: No direct impact mentioned, but general market sentiment can indirectly affect employee morale or stock-based compensation value.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported ranges upon request to the Issuer, any security holder, or the SEC staff.

Key Dates

Recommendation

Keywords

Astera Labs, ALAB, Jitendra Mohan, CEO, Insider Sale, Form 4, SEC Filing, Stock Transaction, Rule 10b5-1 Plan, Common Stock